Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

HYDROXYPROPYL METHYLCE

Active
SPE2DP-26-T-4086Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Hydroxypropyl methylcellulose ophthalmic solution in 1 mL units, formulated as a 2% viscoelastic agent, is specified for use in high-volume, small-incision cataract surgery and other applications such as lens inserter lubrication. Each box contains six single-use units, with the contract calling for ten boxes, totaling sixty units. The product is regulated by the FDA and must be manufactured by Bausch & Lomb Incorporated under part number CC065S with the NSN 6505-01-633-1037. It has a fixed 24-month shelf life from the manufacture date, which is non-extendable, and must be clearly labeled with the manufacturer’s name, date of manufacture, expiration date, contract number, lot number, and national stock number. Packaging and marking must strictly comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and each unit must be sealed in a protective container suitable for preventing damage or breakage. Shipping containers must ensure safe, cost-effective delivery to the destination point of JBER, Alaska, under FOB destination terms, with a required delivery window of five days. The contract enforces a zero variance in quantity and includes full adherence to DLA packaging and hazardous material shipping protocols, with transportation details governed by DLAD Proc Notes C19 and C20. All items are subject to inspection and acceptance at the delivery point, and technical and quality requirements referenced by R and I numbers are incorporated per the DLA Master List.

General Info

Sixty 1 mL 2% HPMC units for cataract surgery, shipped to JBER, Alaska, by Bausch & Lomb under strict FDA and DLA compliance.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

5955 ZEAMER AVE, JBER, AK, 99506-3702, US

Set-Aside

NONE

Documents

(1)

Request for Quotations SPE2DP-26-T-4086

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Alec Deichman
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
HYDROXYPROPYL METHYLCELLULOSE OPHTHALMIC
HYDROXYPROPYL METHYLCELLULOSE OPHTHALMIC SOLUTION
OCUCOAT VISCOELASTIC 1ML, FORMULATED FROM A 2%
HYDROXYPROPYL METHYLCELLULOSE SOLUTION, IDEAL FOR
HIGH-VOLUME, SMALL-INCISION CATARACT SURGERY, CAN
BE USED FOR A VARIETY OF APPLICATIONS, INCLUDING
LENS INSERTER LUBRICATION
.
1 BX = 6 EA
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
. RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
LABELING AND MARKING: MUST INCLUDE:
NATIONAL STOCK NUMBER MANUFACTURER DATE
OF MANUFACTURER, EXPIRATION DATE OR
RETEST DATE CONTRACT NUMBER LOT NUMBER.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
SPE2DP-26-T-4086
SECTION B
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
BAUSCH & LOMB INCORPORATED 93180 P/N CC065S
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017450064 0001 BX 10.000
NSN/MATERIAL:6505016331037
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:A
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
SPE2DP-26-T-4086
SECTION B
PR: 7017450064 PRLI: 0001 CONT’D
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
IP025: PACKAGING, MARKING, AND SHIPPING OF HAZARDOUS MATERIALS
PARCEL POST ADDRESS:
HT1205
673RD MDSS SGSM PA
CP 907 580 6301
5955 ZEAMER AVE
JBER AK 99506-3702
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
HT1205
673RD MDSS SGSM PA
CP 907 580 6301
5955 ZEAMER AVE
JBER AK 99506-3702
US
M/F: (TCN) HT120561894236
RDD:
PROJ: TP 1
SUPP ADD: 51561U SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 03
DIC: A01 DIST: ADV: 2A FC: J6
Need Ship Date:00/00/0000 Original Required Delivery Date:07/14/2026
SPE2DP-26-T-4086 NSN/Part Number: 6505-01-633-1037 Quantity: 10 BX Purchase Request: 7017450064QTY: 10 Delivery: 5 days ADO

Similar Contracts

NAICS: 325412
New
DIBBS
ACYCLOVIR TABLETSACYCLOVIR TABLETS, 800 MG, are being procured under contract SPE2DP-26-T-4088 with a total quantity of 4 bottles, each containing 100 tablets, as defined by the unit of issue BT. The supplier must provide the product in commercial packaging that protects against damage and breakage, with exterior shipping containers suitable for safe delivery by common carriers at the lowest cost to the designated destination. All packaging and marking must comply with Medical Marking Standard No. 1, which replaces MIL-STD-129, and technical and quality requirements referenced by R or I numbers are governed by the DLA Master List of Technical and Quality Requirements. The product must bear one of the approved NDC codes: 60429-0713-01, 00093-8947-01, 00173-0945-55, 61442-0113-01, 00378-0302-01, 51407-0146-01, or 60505-5307-01. The item is classified as a TYPE I (CODE M) with a fixed 24-month shelf life that cannot be extended. Mercury or mercury-containing compounds are prohibited unless functionally necessary and compliant with NAVSEA standards, such as in certain instruments or batteries. Delivery is FOB destination within five days of contract award, with no variance permitted in quantity, and inspection and acceptance occur at the point of delivery. The contract is issued by the Department of Defense under NAICS code 325412, with performance location at Fort Bragg, North Carolina, and point of contact at Timothy McCauley for inquiries.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
DEXTROSE AND SODIUM CHDextrose and Sodium Chloride Injection USP, provided in sterile, nonpyrogenic, single-dose containers, is intended for intravenous use only and contains 5 grams of hydrous dextrose and 0.45 grams of sodium chloride per 100 mL, with each bag holding 1 liter. The product is latex-free but contains DEHP and must be stored at controlled room temperature between 20 to 25°C, protected from excessive heat and freezing. Each package contains twelve 1-liter bags, and the solution must be visually inspected for clarity and intact seals prior to use. The item is regulated by the FDA with a nonextendable shelf life of 30 months and must be marked in full compliance with Medical Marking Standard No. 1 and MIL-STD-129. Packaging must adhere to DLA’s procurement requirements, with commercial packaging under ASTM D3951 unless otherwise superseded by DLA technical standards. The manufacturer is ICU Medical Sales, Inc., identified by NDC 00990-7926-09. The contract, issued under solicitation SPE2DP-26-T-4076, requires delivery of one box containing twelve 1-liter bags to FPO AP 96692 within 20 days of award, with zero variance allowed in quantity. Delivery is FOB destination, inspected and accepted at the delivery point. The item is assigned NSN 6505-00-116-1025 and is subject to covered defense information requirements. The contract specifies a required delivery date of July 14, 2026, with no alternate ship date provided. All shipments must follow DLA transport protocols and are tied to project JP5 TP 2, with primary point of contact Daniel Porter at the Department of Defense, Medical Supply Chain PHARM FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
FLUCONAZOLE TABLETSFluconazole tablets 150 mg are procured in individually sealed blister strips containing 12 tablets per unit, with the unit of issue defined as a package. Each unit must have a minimum shelf life of 24 months from the date of manufacture, and no more than three months may have elapsed between the date of manufacture and delivery to the government. The product must comply with the Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all packaging and labeling must adhere to commercial standards ensuring protection from damage and safe transportation via common carrier. Mercury and mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the product, except for specific approved uses such as batteries or instrument components, which must be contained within a secondary boundary and meet NAVSEA 5100-003D requirements. The item is identified by NSN 6505013953039 and is subject to DLA’s Master List of Technical and Quality Requirements, with applicable revisions governed by the solicitation or award date. Deliveries must be made FOB destination within 20 days, with no tolerance for quantity variance. Inspection and acceptance occur at the point of delivery, and pre-delivery packaging must conform to MIL-STD-2073-1E. The contract is issued under solicitation SPE2DP-26-T-4081, with a response deadline of July 20, 2026, and is managed by the Department of Defense’s Medical Supply Chain PFS. The manufacturer is identified by NDC codes from Golden State Medical Supply Inc. and ANIP Acquisition Co.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANSPOVIDONE-IODINE CLEANSING SOLUTION, USP, containing 7.5% active ingredient, is specified for external use only and must be delivered in 1-gallon bottles with a unit of issue designated as BT. The product requires a minimum of 31 months of remaining shelf life upon delivery to the first government activity, with a total shelf life of 36 months, non-extendable, and must be stored at 25°C (77°F) with allowable excursions between 15°C and 30°C (59°F–86°F). Packaging must comply with DLA’s Packaging Requirements for Procurement and Medical Marking Standard No. 1, superseding MIL-STD-129, and all containers must be commercially sealed to prevent damage during transit. The product is classified as hazardous under Federal Standard No. 313-E, requiring submission of updated Safety Data Sheets and HCS-compliant labels aligned with OSHA’s Globally Harmonized System, along with employee training on these requirements. All shipments must be delivered FOB destination within 20 days, with no variance in quantity permitted, and inspected upon arrival. The item is regulated by the FDA and must be marked, labeled, and palletized according to DLA standards, with transportation directed via traceable means excluding parcel post. Delivery is scheduled for USS ZUMWALT DDG 1000 at FPO AP 96693, with the original required delivery date set for July 14, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMIErythromycin Ophthalmic Ointment, USP, is a sterile, topical antibiotic product containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, formulated for ophthalmic use in single-dose tubes of 3.5 grams each. Each unit is packaged as a 24-tube unit, with a total shelf life of 36 months, requiring a minimum of 31 months of remaining shelf life upon delivery to the first government activity. The product must be stored at controlled room temperature between 15°C and 30°C (59°F–86°F), protected from excessive heat and freezing. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and adherence to the DLA Master List of Technical and Quality Requirements is mandatory, taking precedence over commercial standards such as ASTM D3951. Packaging must ensure protection from damage and enable safe, cost-effective delivery via common carrier to designated military installations, with shipment required by the fastest traceable means, excluding parcel post. The contract specifies four separate delivery lines totaling eight packages, with shipments directed to Fort Bragg, Fort Lewis, Fort Campbell, and additional Fort Bragg locations. Each delivery line has a five-day delivery window, FOB destination, and no quantity variance allowed. The item’s NSN is 6505011897090, and the manufacturer is PADAGIS US LLC with NDC 00574-4024-39. The product is regulated by the FDA, and buyers must route referrals through EBS for confirmation. All units must be palletized according to DLA packaging standards and clearly marked in accordance with the specified medical marking protocol. The solicitation number is SPE2DP-26-T-4083, with a required delivery date of July 14, 2026, and the contracting official is James McCullough of the Department of Defense’s Medical Supply Chain.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details